Veterinary Medicines

Rycarfa 50 mg tablets for dogs

Authorised
  • Carprofen
Download as PDF

Product identification

Medicine name:
Rycarfa 50 mg tablets for dogs
Carprox vet 50 mg δισκία για σκύλους
Active substance:
  • Carprofen
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Carprofen
    50.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AE91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:
  • Blister (OPA/Al/PVC-Al): 20 tablets (10 tablets/blister) in a box
  • Blister (OPA/Al/PVC-Al): 50 tablets (10 tablets/blister) in a box
  • Blister (OPA/Al/PVC-Al): 100 tablets (10 tablets/blister) in a box
  • Blister (OPA/Al/PVC-Al): 500 tablets (10 tablets/blister) in a box

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • TAD Pharma GmbH
  • Krka-Farma d.o.o.
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 8295/28-01-2019/K-0201202
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0316/002
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Italy
  • Netherlands
  • Norway
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 24/08/2025
Download
Greek (PDF)
Published on: 8/07/2022
Download

Combined File of all Documents

English (PDF)
Published on: 24/08/2025
Download